President Donald Trump's administration has decided not to cover expensive, high-demand obesity treatments under the ...

The Trump administration has chosen not to finalize a rule proposed by the Biden administration that would have allowed ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump officials reject Medicare coverage ...

Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.

The Biden administration proposal would have significantly expanded access to obesity to millions of Americans but would have cost the government billions.

The Centers for Medicare & Medicaid Services said on Friday it did not move forward with a proposal put forth by the Biden administration on Medicare coverage of weight-loss drugs such as Novo Nordisk ...

It seems like everyone and their sister is taking a GLP-1 (“glucagon-like peptide-1 receptor agonists,” if you’re feeling nasty), or is at least thinking about it. These meds—which include Ozempic, ...

The telehealth company Hims & Hers Health is expanding its weight-loss offerings by adding new medications to its platform.